My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON.

    Silva SY, Rueda LC, Márquez GA, López M, Smith DJ, Calderón CA, Castillo JC, Matute J, Rueda-Clausen CF, Orduz A, Silva FA, Kampeerapappun P, Bhide M, López-Jaramillo P.

    Trials. 2007 Sep 26;8:26.PMID: 17897470 [PubMed]Related articlesFree article

    2.

    Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629].

    Silva SY, Rueda LC, López M, Vélez ID, Rueda-Clausen CF, Smith DJ, Muñoz G, Mosquera H, Silva FA, Buitrago A, Díaz H, López-Jaramillo P.

    Trials. 2006 May 15;7:14.PMID: 16700912 [PubMed]Related articlesFree article

    4.

    Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.

    Kalani M, Apelqvist J, Blombäck M, Brismar K, Eliasson B, Eriksson JW, Fagrell B, Hamsten A, Torffvit O, Jörneskog G.

    Diabetes Care. 2003 Sep;26(9):2575-80.PMID: 12941721 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.

    Hanft JR, Pollak RA, Barbul A, van Gils C, Kwon PS, Gray SM, Lynch CJ, Semba CP, Breen TJ.

    J Wound Care. 2008 Jan;17(1):30-2, 34-7.PMID: 18210954 [PubMed - indexed for MEDLINE]Related articles

    6.

    Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo.

    Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW.

    Diabetes Care. 1992 Nov;15(11):1598-604.PMID: 1468291 [PubMed - indexed for MEDLINE]Related articles

    7.

    Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.

    Ennis WJ, Foremann P, Mozen N, Massey J, Conner-Kerr T, Meneses P.

    Ostomy Wound Manage. 2005 Aug;51(8):24-39. Erratum in: Ostomy Wound Manage. 2005 Sep;51(9):14. PMID: 16234574 [PubMed - indexed for MEDLINE]Related articles

    8.

    A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.

    Driver VR, Hanft J, Fylling CP, Beriou JM, Autologel Diabetic Foot Ulcer Study Group.

    Ostomy Wound Manage. 2006 Jun;52(6):68-70, 72, 74 passim.PMID: 16799184 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.

    Tom WL, Peng DH, Allaei A, Hsu D, Hata TR.

    Arch Dermatol. 2005 Nov;141(11):1373-7.PMID: 16301384 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.
    12.

    Effectiveness of acupuncture, special dressings and simple, low-adherence dressings for healing venous leg ulcers in primary healthcare: study protocol for a cluster-randomized open-labeled trial.

    Vas J, Modesto M, Mendez C, Perea-Milla E, Aguilar I, Carrasco-Lozano JM, Faus V, Martos F.

    BMC Complement Altern Med. 2008 Jun 11;8:29.PMID: 18547419 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple-blind, placebo-controlled, clinical trial.

    Rullan M, Cerdà L, Frontera G, Masmiquel L, Llobera J.

    Diabet Med. 2008 Sep;25(9):1090-5. Erratum in: Diabet Med. 2008 Oct;25(10):1257. PMID: 19183313 [PubMed - indexed for MEDLINE]Related articles

    14.

    The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration.

    El-Nahas M, Gawish H, Tarshoby M, State O.

    J Wound Care. 2009 Jan;18(1):33-7.PMID: 19131916 [PubMed - indexed for MEDLINE]Related articles

    15.

    Clinical evaluation of a semipermeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcers.

    Blackman JD, Senseng D, Quinn L, Mazzone T.

    Diabetes Care. 1994 Apr;17(4):322-5.PMID: 8026290 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers]

    Lázaro-Martínez JL, García-Morales E, Beneit-Montesinos JV, Martínez-de-Jesús FR, Aragón-Sánchez FJ.

    Cir Esp. 2007 Jul;82(1):27-31. Spanish. PMID: 17580028 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.

    Lyons TE, Miller MS, Serena T, Sheehan P, Lavery L, Kirsner RS, Armstrong DG, Reese A, Yankee EW, Veves A.

    Am J Surg. 2007 Jan;193(1):49-54.PMID: 17188087 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients: results of a randomized controlled trial.

    Meaume S, Kerihuel JC, Constans T, Teot L, Lerebours E, Kern J, Bourdel Marchasson I.

    J Nutr Health Aging. 2009 Aug;13(7):623-30.PMID: 19621198 [PubMed - indexed for MEDLINE]Related articles

    20.

    Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.

    Langer A, Rogowski W.

    BMC Health Serv Res. 2009 Jul 10;9:115. Review.PMID: 19591680 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk